Navigation Links
Health IT Services Group's Acumen EHR, Version 6.0, Receives ONC-ATCB 2011/2012 Certification
Date:1/4/2011

NASHVILLE, Tenn., Jan. 4, 2011 /PRNewswire/ -- Health IT Services Group announced today that Acumen EHR, version 6.0, is 2011/2012 compliant and was certified as a Complete EHR on December 30, 2010, by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ATCB, in accordance with the applicable Eligible Provider certification criteria adopted by the Secretary of Health and Human Services. The 2011/2012 criteria support the Stage 1 meaningful use measures required to qualify eligible providers and hospitals for funding under the American Recovery and Reinvestment Act (ARRA).

"As the national leader in the nephrology specific EHR market, we are delighted to achieve this important milestone," said Terry Ketchersid, M.D., VP and Medical Officer for Health IT Services Group. "Acumen is able to meet the needs of every nephrologist in practice today, including those who wish to demonstrate meaningful use."

The ONC-ATCB 2011/2012 certification program tests and certifies that Complete EHRs meet all of the 2011/2012 criteria and EHR Modules meet one or more – but not all – of the criteria approved by the Secretary of Health and Human Services (HHS) for either eligible provider or hospital technology.

"CCHIT is pleased to be testing and certifying products so that companies are now able to offer these products to providers who wish to purchase and implement certified EHR technology and achieve meaningful use in time for the 2011-2012 incentives," said Karen M. Bell, M.D., M.S.S., Chair, CCHIT.

Acumen EHR, version 6.0's certification number is CC-1112-207410-1. ONC-ATCB 2011/2012 certification conferred by CCHIT does not represent an endorsement of the certified EHR technology by the U.S. Department of Health and Human Services nor does it guarantee the receipt of incentive payments.

The clinical quality measures to which Acumen EHR has been certified include:

NQF 0421, NQF 0013, NQF 0028, NQF 0041, NQF 0024, NQF 0038, NQF 0027, NQF 0031, NQF 0043, NQF 0061, NQF 0083, and NQF 0088

Acumen EHR, version 6.0 is also certified in CCHIT's separate and independently developed certification program. Acumen EHR is a CCHIT Certified® 2011 Ambulatory EHR. Health IT Services Group has certified its EHR technology in both programs to provide greater assurance to its customers.

About Health IT Services Group

HITSG is a wholly-owned subsidiary of Fresenius Medical Care North America, based in Brentwood, Tennessee. HITSG was formed to develop and deliver intuitive software tools to assist Nephrologists in the practice of medicine. The Acumen solution was designed by nephrologists and made available under an internet-based, application service provider (ASP) model. HITSG partners with dialysis organizations and systems, hospitals, vascular access centers, laboratory systems, HIEs and practice management systems to drive workflow and effectively streamline access, storage, and distribution of patient treatment information into the Acumen system.  More information regarding Acumen EHR and Health IT Services Group can be found at www.AcumenEHR.com.   

About CCHIT

The Certification Commission for Health Information Technology (CCHIT®) is an independent, 501(c)3 nonprofit organization with the public mission of accelerating the adoption of robust, interoperable health information technology.  The Commission has been certifying electronic health record technology since 2006 and is approved by the Office of the National Coordinator for Health Information Technology (ONC) of the U.S. Department of Health and Human Services (HHS) as an Authorized Testing and Certification Body (ONC-ATCB).  More information on CCHIT, CCHIT Certified® products and ONC-ATCB certified electronic health record technology is available at http://cchit.org.

About ONC-ATCB 2011/2012 certification

The ONC-ATCB 2011/2012 certification program tests and certifies that EHR technology is capable of meeting the 2011/2012 criteria approved by the Secretary of Health and Human Services (HHS). The certifications include Complete EHRs, which meet all of the 2011/2012 criteria for either eligible provider or hospital technology and EHR Modules, which meet one or more – but not all – of the criteria. ONC-ATCB certification aligns with Health Information Technology: Initial Set of Standards, Implementation Specifications, and Certification Criteria for Electronic Health Record Technology published in the Federal Register in July 2010 and strictly adheres to the test procedures published by the National Institute of Standards and Technology (NIST) at the time of testing.  ONC-ATCB 2011/2012 certification conferred by the Certification Commission for Health Information Technology (CCHIT®) does not represent an endorsement of the certified EHR technology by the U.S. Department of Health and Human Services nor does it guarantee the receipt of incentive payments.

"CCHIT®" and "CCHIT Certified®" are registered trademarks of the Certification Commission for Health Information Technology.

Contact:
Jason Holcomb
Director of Business Development
615.345.4722
Jason.holcomb@hitsg.com




'/>"/>
SOURCE Health IT Services Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Tone Deafness Explained, from the Harvard Health Letter
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
8. ViroPharma to Present at Three Upcoming Healthcare Conferences
9. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
10. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
11. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... 29, 2017 Research and Markets has announced ... to 2023" report to their offering. ... The ablation device global market is ... million by 2023. Ablation is the minimally invasive ... from cancerous or diseased tissue removal, to the removal of abnormally ...
(Date:3/29/2017)...  Spiral Therapeutics, Inc. today announced the signature ... for the worldwide exclusive rights to Bionure,s lead ... of otolaryngology for aggregate payments of up to ... provides Spiral with the option to license two ... Under the terms of the agreement, Spiral will ...
(Date:3/29/2017)... , March 29, 2017   Royal ... leader in health technology, and PathAI, a company ... collaborating with the aim to develop solutions that ... of cancer and other diseases. The partnership aims ... enabling this form of artificial intelligence to be ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... March 29, 2017 , ... AngioGenesis Labs sold 300 ... Mississippi. AngioGenesis Labs, makers of HeartBoost, BrainBest and BeautyBest, achieved these results while ... HeartBoost, an over the counter heart healthy drink, can reduce Arterial Plaque, Lower ...
(Date:3/29/2017)... ... 29, 2017 , ... Dr. Angela Cotey, a noted general dentist in Mt. ... patients, with or without a referral. Dr. Cotey knows that interceptive orthodontics ... experience. When patients receive early treatment, they may achieve straight teeth with less treatment ...
(Date:3/29/2017)... , ... March 29, 2017 , ... Curio Wellness ... to announce the finalization of the company’s executive management team with prominent executives from ... operations is Curio Wellness’ Chief Operating Officer, Ted Dumbauld , who has more ...
(Date:3/29/2017)... ... March 29, 2017 , ... Immunotherapy has emerged as one ... cancers and is touted to be the next revolution in our fight against this ... in the form of immune checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , ...
(Date:3/29/2017)... Philadelphia, PA (PRWEB) , ... March 29, 2017 , ... ... Moelis, W’80, WG’81, and Julie Taffet Moelis, W’81, have made a $10 million gift ... a deferred admission opportunity that will provide a pathway to a Wharton MBA for ...
Breaking Medicine News(10 mins):